Colon Cancer News

CancerConnect colon cancer news, tips, and features provide breaking research stories, helpful tips, and inspiring features related to ovarian cancer. The unique daily cancer news service evaluates all aspects of colon cancer research and reports on the developments that are most important to cancer patients and healthcare providers, while the tips and features offer insight into all aspects of colon cancer treatment and survivorship.

Share

Colon Cancer News


Counsyl Announces Major Oncology Expansion to Advance Genetic Screening for Cancer Risk (May 25, 2016)

Counsyl launches oncology business unit, an expanded test to assess risk for inherited forms of cancer, and tools to improve genetic screening rates across the healthcare system Counsyl, a DNA testing... Continue Reading

Herceptin® Plus Tykerb® Promising for HER2-Positive Colorectal Cancer (May 11, 2016)

The treatment combination consisting of Herceptin (trastuzumab) plus Tykerb (lapatinib) provides significant anti-cancer activity in colorectal cancer that overexpresses the human epidermal growth factor... Continue Reading

Another Study Confirms That Daily Aspirin Lowers Risk of Colorectal & Other GI Tract Cancers (May 9, 2016)

The regular use of aspirin significantly reduces the overall risk of cancer, especially colorectal and other gastrointestinal tract cancers, according to a study published in JAMA Oncology.1 The recent... Continue Reading

EPI proColon® – Novel Blood Screening Test Approved for Colorectal Cancer Detection (May 2, 2016)

The United States Food and Drug Administration (FDA) has approved Epi proColon®, a test that screens for colorectal cancer from a simple blood draw. The approval specifies that EPI proColon is only indicated... Continue Reading

Have a Question about Lynch Syndrome? You Can Ask the Expert! (April 27, 2016)

CancerConnect Presents: Ask the Expert with Dana-Farber Cancer Institute’s Dr. Perez Lynch Syndrome: Get the Facts about this Hereditary Cancer Syndrome Kimberly Perez, MD CancerConnect announces the... Continue Reading

Another Reason to Break the Habit: Smoking Alters Bacterial Balance in Mouth (April 12, 2016)

Smoking drastically alters the oral microbiome, the mix of roughly 600 bacterial species that live in people’s mouths. This is the finding of a study led by NYU Langone Medical Center and its Laura... Continue Reading

Anesthesia Increases Colonoscopy Risks (March 4, 2016)

Though colonoscopy is often performed with anesthesia, a recent study published in the journal Gastroenterology has found that sedation increases the risk of complications.1 A colonoscopy is a type of... Continue Reading

Pass It On: It’s Colorectal Cancer Awareness Month (March 3, 2016)

The colon and rectum are parts of the digestive system, and make up the large intestine. Most of the large intestine is made up of the colon, a muscular tube about five feet long, with the rectum making... Continue Reading

Vistogard® Approved for Life-Threatening Toxicities of Certain Chemotherapy Agents (February 11, 2016)

The United States Food and Drug Administration (FDA) approved Vistogard (uridine triacetate) for the treatment of life-threatening toxicities caused by the chemotherapy drugs fluorouracil or capecitabine. The... Continue Reading

Colorectal Cancer: Year in Review (February 3, 2016)

After several years of exciting developments in colorectal cancer research and therapy, progress continued throughout 2015. The FDA approved a new drug to treat colorectal cancer, and much research has... Continue Reading

More Colon Cancer News

Latest Colon Cancer News By Stage


Screening/Prevention

Counsyl Announces Major Oncology Expansion to Advance Genetic Screening for Cancer Risk (May 25, 2016)

Counsyl launches oncology business unit, an expanded test to assess risk for inherited forms of cancer, and tools to improve genetic screening rates across the healthcare system Counsyl, a DNA testing and genetic counseling service, today announced... Continue Reading

EPI proColon® – Novel Blood Screening Test Approved for Colorectal Cancer Detection (May 2, 2016)

The United States Food and Drug Administration (FDA) has approved Epi proColon®, a test that screens for colorectal cancer from a simple blood draw. The approval specifies that EPI proColon is only indicated for individuals at an average risk of developing... Continue Reading

Have a Question about Lynch Syndrome? You Can Ask the Expert! (April 27, 2016)

CancerConnect Presents: Ask the Expert with Dana-Farber Cancer Institute’s Dr. Perez Lynch Syndrome: Get the Facts about this Hereditary Cancer Syndrome Kimberly Perez, MD CancerConnect announces the opportunity to engage with a hereditary cancers expert,... Continue Reading

Another Reason to Break the Habit: Smoking Alters Bacterial Balance in Mouth (April 12, 2016)

Smoking drastically alters the oral microbiome, the mix of roughly 600 bacterial species that live in people’s mouths. This is the finding of a study led by NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center, published online... Continue Reading

Anesthesia Increases Colonoscopy Risks (March 4, 2016)

Though colonoscopy is often performed with anesthesia, a recent study published in the journal Gastroenterology has found that sedation increases the risk of complications.1 A colonoscopy is a type of exam that a doctor uses to check the lining of the... Continue Reading

More Screening and Prevention

Adjuvant (I-III, A-C) Colon Cancer

More Effective Surgery for Colon Cancer with Laparoscopic versus Open Colectomy (April 22, 2015)

Less invasive surgery for colon cancer with laparoscopic colectomy improves outcomes. These findings were reported in the Journal of the National Cancer Institute. Historically, surgical treatment for colon cancer involved a procedure called open colectomy... Continue Reading

Treatment Outcomes in Stage III Colon Cancer Appear Better in Aspirin, COX-2 Inhibitor Users (March 23, 2015)

CancerConnect News:   According to the results of a study recently reported in the Journal of the National Cancer Institute, patients with stage III colon cancer who take aspirin or other agents that inhibit cyclooxygenase-2 near the time of adjuvant... Continue Reading

Preoperative Arterial Chemotherapy Appears Superior to Post-operative Chemotherapy in the Management of Early Stage Colorectal Cancer (March 18, 2015)

CancerConnect News: Doctors from China have reported at the annual Gastrointestinal Cancers Symposium sponsored by the American Society of Clinical Oncology in San Francisco that giving preoperative chemotherapy directly into the common hepatic artery... Continue Reading

Advances in Genomic Testing-What you Need to Know (September 29, 2014)

Q: What is genomic testing? A: Genomic testing looks at a group of genes and their varying levels of expression. This gene expression or activity can characterize how genes interact with one another and predict the behavior of certain tissues within... Continue Reading

Oncotype DX Colon Cancer Test May Reduce Medical Costs Associated with Stage II Disease While Increasing Patient Well-being (September 22, 2014)

REDWOOD CITY, Calif., Sept. 12, 2014 /PRNewswire/ — Genomic Health, Inc. (Nasdaq: GHDX) today announced that PharmacoEconomics published positive results from a health economic analysis suggesting that use of the Oncotype® DX colon cancer... Continue Reading

More Adjuvant (I-III, A-C) Colon Cancer

Stage IV (D)/Relapsed Colon Cancer

Lonsurf® Approved for the Treatment of Colorectal Cancer (September 30, 2015)

The United States Food and Drug Administration (FDA) has approved the oral agent, Lonsurf® (trifluridine and tipiracil), for the treatment of colorectal cancer. Colorectal cancer remains the second leading cause of cancer-related deaths in the U.S. although... Continue Reading

XBiotech Completes Enrollment for Xilonix™ Phase III Registration Study in Europe, US Trial Ongoing (August 24, 2015)

XBiotech has announced that it has completed enrollment of the Company’s pivotal, randomized double-blinded placebo controlled Phase III study in Europe of Xilonix™ for the treatment of advanced colorectal cancer. The US based trial is ongoing at... Continue Reading

Vectibix® Improves Survival in Patients with Wild-Type KRAS Metastatic Colorectal Cancer after Progression on Chemotherapy (August 11, 2015)

Vectibix® (panitumumab) appears to improve overall survival among patients with wild-type KRAS metastatic colorectal cancer that has progressed on or following chemotherapy. A Phase III trial of Vectibix is currently underway, but researchers have announced... Continue Reading

New Biomarkers Might Help Personalize Metastatic Colorectal Cancer Treatment (June 23, 2015)

Metastatic colorectal cancer patients tend to live longer when they respond to the first line of chemotherapy their doctors recommend. To better predict how patients will respond to chemotherapy drugs before they begin treatment, researchers at University... Continue Reading

New Drug Combination Extends Survival of Patients with Metastatic Colorectal Cancer (June 18, 2015)

A drug developed 50 years ago and abandoned because it was considered to be too toxic has gained a second life in an international clinical trial. Research led by scientists at Dana-Farber Cancer Institute showed the drug and a potentiating agent lengthened... Continue Reading

More Stage IV (D)/Relapsed Colon Cancer

CancerConnect Cancer Commuity & Discussions


Cancer Types

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS